Different preparations of tacrolimus and medication errors

American Journal of Transplantation

Volumn 8, Issue 9, 2008, Pages 1962-

  Woywodt, A ^a   Delargy, M ^a   Thain, Z ^a  

^a LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVAGRAF; TACRO; TACROLIMUS;

CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG SYNTHESIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; LETTER; LIVER GRAFT REJECTION; MEDICATION ERROR; PATIENT COMPLIANCE; PRIORITY JOURNAL;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS; TACROLIMUS;

EID: 49649089130     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02325.x     Document Type: Letter

References (5)

1. Heffron TG, Pescovitz MD, Florman S et al. Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. Am J Transplant 2007 7 : 1609 1615.
2. Silva HT, Jr., Yang HC, Abouljoud M et al. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. Am J Transplant 2007 7 : 595 608.
3. N.N. Astellas asks pharmacists to check tacrolimus brand. Available from : http://www.pjonline.comeditorial/20080405/news/p389tacrolinus.html. Accessed June 10, 2008.
4. First MR. First clinical experience with the new once-daily formulation of tacrolimus. Ther Drug Monit 2008 30 : 159 66.
5. EMEA. Advagraf European Public Assessment Report Available from : http://www.emea.europa.eu/humandocs/PDFs/EPAR/advagraf/H-712-en6.pdf. Accessed April 26, 2008.